Triferic AVNU
ApprovedCompleted 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
End Stage Renal Disease
Conditions
End Stage Renal Disease
Trial Timeline
Apr 19, 2021 → Jun 19, 2021
NCT ID
NCT04689932About Triferic AVNU
Triferic AVNU is a approved stage product being developed by Rockwell Medical for End Stage Renal Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT04689932. Target conditions include End Stage Renal Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
2
Novelty
10
Community
12
Clinical Trials (2)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05110768 | Phase 2 | UNKNOWN |
| NCT04689932 | Approved | Completed |
Competing Products
20 competing products in End Stage Renal Disease